{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:51:10Z","timestamp":1793724670701,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03288-5","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T10:15:35Z","timestamp":1755684935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pleural fluid biomarkers to predict response to pleurodesis or indwelling pleural catheter for malignant pleural effusion: still a long way to go"],"prefix":"10.1186","volume":"26","author":[{"given":"Katrine","family":"Fjaellegaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Ahmadzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Porcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uffe","family":"Bodtger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"3288_CR1","doi-asserted-by":"publisher","unstructured":"Clive AO, Jones HE, Bhatnagar R, Preston NJ, Maskell N. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev. 2016;5CD010529. https:\/\/doi.org\/10.1002\/14651858.CD010529.pub2.","DOI":"10.1002\/14651858.CD010529.pub2"},{"issue":"12","key":"3288_CR2","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","volume":"69","author":"AO Clive","year":"2014","unstructured":"Clive AO, Kahan BC, Hooper CE, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014;69(12):1098\u2013104. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-205285.","journal-title":"Thorax"},{"key":"3288_CR3","doi-asserted-by":"publisher","unstructured":"Bibby AC, Dorn P, Psallidas I, et al. ERS\/EACTS statement on the management of malignant pleural effusions. Eur Respir J. 2018;52(1). https:\/\/doi.org\/10.1183\/13993003.00349-2018.","DOI":"10.1183\/13993003.00349-2018"},{"issue":"26","key":"3288_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24260","volume":"24","author":"R Bhatnagar","year":"2020","unstructured":"Bhatnagar R, Luengo-Fernandez R, Kahan BC, Rahman NM, Miller RF, Maskell NA. Thoracoscopy and Talc poudrage compared with intercostal drainage and Talc slurry infusion to manage malignant pleural effusion: the tapps Rct. Health Technol Assess (Rockv). 2020;24(26):1\u201389. https:\/\/doi.org\/10.3310\/hta24260.","journal-title":"Health Technol Assess (Rockv)"},{"issue":"Suppl 3","key":"3288_CR5","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/thorax-2022-219784","volume":"78","author":"ME Roberts","year":"2023","unstructured":"Roberts ME, Rahman NM, Maskell NA, et al. British thoracic society guideline for pleural disease. Thorax. 2023;78(Suppl 3):s1\u201342. https:\/\/doi.org\/10.1136\/thorax-2022-219784.","journal-title":"Thorax"},{"issue":"Suppl 3","key":"3288_CR6","doi-asserted-by":"publisher","first-page":"s43","DOI":"10.1136\/thorax-2022-219371","volume":"78","author":"R Asciak","year":"2023","unstructured":"Asciak R, Bedawi EO, Bhatnagar R, et al. British thoracic society clinical statement on pleural procedures. Thorax. 2023;78(Suppl 3):s43\u201368. https:\/\/doi.org\/10.1136\/thorax-2022-219371.","journal-title":"Thorax"},{"issue":"14","key":"3288_CR7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1056\/nejmoa1716883","volume":"378","author":"R Bhatnagar","year":"2018","unstructured":"Bhatnagar R, Keenan EK, Morley AJ, et al. Outpatient Talc administration by indwelling pleural catheter for malignant effusion. N Engl J Med. 2018;378(14):1313\u201322. https:\/\/doi.org\/10.1056\/nejmoa1716883.","journal-title":"N Engl J Med"},{"issue":"9","key":"3288_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","volume":"6","author":"S Muruganandan","year":"2018","unstructured":"Muruganandan S, Azzopardi M, Fitzgerald DB, et al. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial. Lancet Respir Med. 2018;6(9):671\u201380. https:\/\/doi.org\/10.1016\/S2213-2600(18)30288-1.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"3288_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/17476348.2020.1746647","volume":"14","author":"M Hassan","year":"2020","unstructured":"Hassan M, Gadallah M, Mercer RM, Harriss E, Rahman NM. Predictors of outcome of pleurodesis in patients with malignant pleural effusion: a systematic review and meta-analysis. Expert Rev Respir Med. 2020;14(6):645\u201354. https:\/\/doi.org\/10.1080\/17476348.2020.1746647.","journal-title":"Expert Rev Respir Med"},{"key":"3288_CR10","unstructured":"Pantazopoulos I. Pleural Fluid Glucose: A Predictor of Unsuccessful Pleurodesis in a Preselected Cohort of Patients with Malignant Pleural Effusion. www.jbuon.com."},{"issue":"1","key":"3288_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejcdt.2014.08.005","volume":"64","author":"S Alsayed","year":"2015","unstructured":"Alsayed S, Marzouk S, Abelhalim S, Mousa E. Malignant pleural effusion biomarkers as predictor for chemical pleurodesis success. Egypt J Chest Dis Tuberculosis. 2015;64(1):153\u201360. https:\/\/doi.org\/10.1016\/j.ejcdt.2014.08.005.","journal-title":"Egypt J Chest Dis Tuberculosis"},{"issue":"3","key":"3288_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ejcdt.2015.05.003","volume":"64","author":"SM Shehata","year":"2015","unstructured":"Shehata SM, Sileem AE, El-Fakharany KM. Pleural fluid CRP, LDH, and pH as predictors of successful pleurodesis in malignant pleural effusions. Egypt J Chest Dis Tuberculosis. 2015;64(3):593\u20139. https:\/\/doi.org\/10.1016\/j.ejcdt.2015.05.003.","journal-title":"Egypt J Chest Dis Tuberculosis"},{"key":"3288_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.lungcan.2019.09.003","volume":"137","author":"M Hassan","year":"2019","unstructured":"Hassan M, Mercer RM, Maskell NA, et al. Survival in patients with malignant pleural effusion undergoing Talc pleurodesis. Lung Cancer. 2019;137:14\u20138. https:\/\/doi.org\/10.1016\/j.lungcan.2019.09.003.","journal-title":"Lung Cancer"},{"key":"3288_CR14","unstructured":"Heffner JE, Nietert PJ, Barbieri C. Pleural Fluid PH as a Predictor of Pleurodesis Failure* Analysis of Primary Data."},{"issue":"1","key":"3288_CR15","first-page":"22","volume":"57","author":"G Ak","year":"2009","unstructured":"Ak G, Metinta\u015f M, Yildirim H, et al. Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients. Tuberk Toraks. 2009;57(1):22\u201331. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19533434.","journal-title":"Tuberk Toraks"},{"issue":"2","key":"3288_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.5507\/bp.2014.038","volume":"159","author":"P Habal","year":"2015","unstructured":"Habal P, Omran N, Jankovicova K, Krejsek J, Mandak J. Predictive value of systemic and local inflammation parameters in Talc pleurodesis assessment. Biomedical Papers. 2015;159(2):234\u201341. https:\/\/doi.org\/10.5507\/bp.2014.038.","journal-title":"Biomedical Papers"},{"issue":"4","key":"3288_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1183\/09031936.06.00097505","volume":"27","author":"K Psathakis","year":"2006","unstructured":"Psathakis K, Calder\u00f3n-Osuna E, Romero-Romero B, Martin-Juan J, Romero-Falc\u00f3n A, Rodriguez-Panadero F. The neutrophilic and fibrinolytic response to Talc can predict the outcome of pleurodesis. Eur Respir J. 2006;27(4):817\u201321. https:\/\/doi.org\/10.1183\/09031936.06.00097505.","journal-title":"Eur Respir J"},{"issue":"4","key":"3288_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/jpm.2012.0521","volume":"16","author":"M Lapidot","year":"2013","unstructured":"Lapidot M, Faber DL, Nir RR, et al. C-reactive protein predicts pleurodesis success in malignant pleural effusion patients. J Palliat Med. 2013;16(4):337. https:\/\/doi.org\/10.1089\/jpm.2012.0521.","journal-title":"J Palliat Med"},{"issue":"6","key":"3288_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00408-007-9042-x","volume":"185","author":"H Yildirim","year":"2007","unstructured":"Yildirim H, Metintas M, Ak G, et al. Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of Talc pleurodesis outcome. Lung. 2007;185(6):349\u201354. https:\/\/doi.org\/10.1007\/s00408-007-9042-x.","journal-title":"Lung"},{"issue":"1","key":"3288_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.lungcan.2008.02.017","volume":"62","author":"H Yildirim","year":"2008","unstructured":"Yildirim H, Metintas M, Ak G, Metintas S, Erginel S. Predictors of Talc pleurodesis outcome in patients with malignant pleural effusions. Lung Cancer. 2008;62(1):139\u201344. https:\/\/doi.org\/10.1016\/j.lungcan.2008.02.017.","journal-title":"Lung Cancer"},{"key":"3288_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12885-016-2529-1","volume":"16","author":"LH Hsu","year":"2016","unstructured":"Hsu LH, Hsu PC, Liao TL, Feng AC, Chu NM, Kao SH. Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study. BMC Cancer. 2016;16:463. https:\/\/doi.org\/10.1186\/s12885-016-2529-1.","journal-title":"BMC Cancer"},{"issue":"2","key":"3288_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.lungcan.2012.03.006","volume":"77","author":"CE Hooper","year":"2012","unstructured":"Hooper CE, Elvers KT, Welsh GI, Millar AB, Maskell NA. VEGF and sVEGFR-1 in malignant pleural effusions: association with survival and pleurodesis outcomes. Lung Cancer. 2012;77(2):443\u20139. https:\/\/doi.org\/10.1016\/j.lungcan.2012.03.006.","journal-title":"Lung Cancer"},{"issue":"4","key":"3288_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.5507\/bp.2015.005","volume":"159","author":"P Habal","year":"2015","unstructured":"Habal P, Omran N, Chek J, Krejsek J, Mandak J. New biomarkers in the selection of patients for talcage of pleural cavity in the palliative therapy of malign pleural exudate. Biomedical Papers. 2015;159(4):576\u201381. https:\/\/doi.org\/10.5507\/bp.2015.005.","journal-title":"Biomedical Papers"},{"key":"3288_CR24","doi-asserted-by":"publisher","unstructured":"Arellano-Orden E, Romero-Romero B, S\u00e1nchez-L\u00f3pez V, Mart\u00edn-Juan J, Rodr\u00edguez-Panadero F, Otero-Candelera R. Survivin is a negative prognostic factor in malignant pleural effusion. Eur J Clin Invest. 2018;48(4). https:\/\/doi.org\/10.1111\/eci.12895.","DOI":"10.1111\/eci.12895"},{"issue":"2","key":"3288_CR25","doi-asserted-by":"publisher","first-page":"E235","DOI":"10.9778\/cmajo.20170163","volume":"6","author":"P Li","year":"2018","unstructured":"Li P, Graver A, Hosseini S, et al. Clinical predictors of successful and earlier pleurodesis with a tunnelled pleural catheter in malignant pleural effusion: a cohort study. CMAJ Open. 2018;6(2):E235\u201340. https:\/\/doi.org\/10.9778\/cmajo.20170163.","journal-title":"CMAJ Open"},{"issue":"2","key":"3288_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/LBR.0000000000000632","volume":"27","author":"JM Porcel","year":"2020","unstructured":"Porcel JM, Torres M, Pardina M, Civit C, Salud A, Bielsa S. Predictors of indwelling pleural catheter removal and infection: A single-center experience with 336 procedures. J Bronchol Interv Pulmonol. 2020;27(2):86\u201394. https:\/\/doi.org\/10.1097\/LBR.0000000000000632.","journal-title":"J Bronchol Interv Pulmonol"},{"issue":"1","key":"3288_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/LBR.0000000000000602","volume":"27","author":"HB Grosu","year":"2020","unstructured":"Grosu HB, Lu W, Ost DE, et al. Pleural fluid cytokine levels at baseline and over time are associated with time to IPC removal: an exploratory study. J Bronchol Interv Pulmonol. 2020;27(1):4\u201313. https:\/\/doi.org\/10.1097\/LBR.0000000000000602.","journal-title":"J Bronchol Interv Pulmonol"},{"issue":"4","key":"3288_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/LBR.0000000000000022","volume":"20","author":"S Shojaee","year":"2013","unstructured":"Shojaee S, Voelkel N, Farkas L, de Wit M, Lee HJ. Transforming growth factor-\u03b21 rise in pleural fluid after tunneled pleural catheter placement: pilot study. J Bronchol Interv Pulmonol. 2013;20(4):304\u20138. https:\/\/doi.org\/10.1097\/LBR.0000000000000022.","journal-title":"J Bronchol Interv Pulmonol"},{"issue":"4","key":"3288_CR29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jtho.2021.01.1616","volume":"16","author":"FS Ou","year":"2021","unstructured":"Ou FS, Michiels S, Shyr Y, Adjei AA, Oberg AL. Biomarker discovery and validation: statistical considerations. J Thorac Oncol. 2021;16(4):537\u201345. https:\/\/doi.org\/10.1016\/j.jtho.2021.01.1616.","journal-title":"J Thorac Oncol"},{"key":"3288_CR30","doi-asserted-by":"publisher","unstructured":"Iqbal B, Choi HJ, Kanellakis NI, Akulian J, Rahman NM. Bedside to bench and back again-translational research in interventional pulmonology. Curr Opin Pulm Med. Published online. 2024. https:\/\/doi.org\/10.1097\/MCP.0000000000001125","DOI":"10.1097\/MCP.0000000000001125"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03288-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03288-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03288-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T10:15:39Z","timestamp":1755684939000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03288-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3288"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03288-5","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"259"}}